Bristol Myers Squibb (BMY) Change in Receivables (2009 - 2026)
Bristol Myers Squibb (BMY) posted Change in Receivables of $95 million for Q3 2026, compared with -$155 million a year earlier and down 92.0% from the prior quarter.
Bristol Myers Squibb (BMY) Change in Receivables (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Change in Receivables at Bristol Myers Squibb was -$428 million; for FY2025, it was $295 million.
- Annual Change in Receivables shows a five-year compound annual growth rate of -14.5% (FY2020 to FY2025).
- In prior years, Bristol Myers Squibb's Change in Receivables was -$264 million in FY2024, $995 million in FY2023 (+50.1%), $663 million in FY2022 (-37.1%) and $1.05 billion in FY2021 (+63.2%).
- Quarterly Change in Receivables has run from a low of -$1.69 billion in Q1 2026 to a high of $1.18 billion in Q2 2026 over five years.
- The strongest year-over-year quarter for Change in Receivables in the past five years was Q4 2023, with growth of 379.2%; the weakest was Q2 2023, with a decline of 90.3%.
- According to Business Quant data, Change in Receivables for the three prior quarters was $1.18 billion (Q2 2026), -$1.69 billion (Q1 2026) and -$19 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | -312.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 108.00 Mn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -52.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 95.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 95.00 Mn |
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | -1.69 Bn |
| Dec 31, 2025 | -19.00 Mn |
| Sep 30, 2025 | -155.00 Mn |
| Jun 30, 2025 | 484.00 Mn |
| Mar 31, 2025 | -15.00 Mn |
| Dec 31, 2024 | -143.00 Mn |
| Sep 30, 2024 | -661.00 Mn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | -479.00 Mn |
| Dec 31, 2023 | 508.00 Mn |
| Sep 30, 2023 | 247.00 Mn |
| Jun 30, 2023 | 65.00 Mn |
| Mar 31, 2023 | 175.00 Mn |
| Dec 31, 2022 | 106.00 Mn |
| Sep 30, 2022 | 674.00 Mn |
| Jun 30, 2022 | 669.00 Mn |
| Mar 31, 2022 | -786.00 Mn |
| Dec 31, 2021 | 168.00 Mn |
Bristol Myers Squibb Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();